Dietlein, F., Kalb, B., Jokic, M., Torgovnick, A., Schmitt, A., Buettner, R., Thomas, R. and Reinhardt, H. C. (2015). Combined Chk1-and MK2-inhibition displays robust synergy in KRAS-mutant cancer. Oncol. Res. Treat., 38. S. 169 - 170. BASEL: KARGER. ISSN 2296-5262

Full text not available from this repository.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Dietlein, F.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kalb, B.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Jokic, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Torgovnick, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schmitt, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Buettner, R.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Thomas, R.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Reinhardt, H. C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-390670
Journal or Publication Title: Oncol. Res. Treat.
Volume: 38
Page Range: S. 169 - 170
Date: 2015
Publisher: KARGER
Place of Publication: BASEL
ISSN: 2296-5262
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
OncologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/39067

Downloads

Downloads per month over past year

Export

Actions (login required)

View Item View Item